Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Keßler, Antje Wick, Andreas von Deimling et al.|Clinical Cancer Research|2023Cited by 27
Supplementary Table S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Keßler, Antje Wick, Daniel Schrimpf et al.|Unknown|2023Cited by 0
Supplementary Table S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Keßler, Antje Wick, Daniel Schrimpf et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Keßler, Antje Wick, Daniel Schrimpf et al.|Unknown|2023Cited by 0
Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Keßler, Antje Wick, Daniel Schrimpf et al.|Unknown|2025Cited by 0